No Image

Cytori’s Cardiac Celution: Encouraging Interim Data

September 23, 2009 vanderson 0

In the area of heart disease, Cytori Therapeutics (NASDAQ: CYTX) is sponsoring two European clinical trials that evaluate the use of adipose-derived stem and regenerative cells (ADRCs) to treat acute myocardial infarction and chronic myocardial ischemia.

No Image

Good News for Market-Leading Stent

March 31, 2009 bjohnson56 0

A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.

No Image

[Video Profile] eCardio Diagnostics

March 23, 2009 bjohnson56 0

Identifying a cardiac arrhythmia is an important first step in diagnosing a potentially life-threatening heart condition. Texas-based eCardio Diagnostics, a leading provider of digital holter monitors, seeks to improve the speed and accuracy of this process.